[The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation].
The inflammatory process plays important role in pathogenesis of some cardiovascular diseases. Atrial fibrillation is atrial arrhythmia with rapid, asynchronous activation of atrial myocytes. The inflammatory process can be responsible for atrial electrical and anatomical remodeling and therefore shifts towards arrhythmia persistence. The presence of systemic inflammation may be assessed by means of C-reactive protein (CRP) measurement. Maximal concentration of CRP coincidences with the peak of paroxysmal atrial fibrillation occurrence in patients after cardiac surgery. In patients with sinus rhythm the concentration of CRP is a risk factor for this arrhythmia in long-term follow-up. In patients with atrial fibrillation mean CRP concentration is 2-fold higher comparing to control group. CRP concentration is higher in patients with chronic than paroxysmal form of this arrhythmia. High CRP level predicts worse results of direct current cardioversion and more frequent paroxysms of atrial fibrillation during follow-up. Besides of, the patients with echocardiographic signs of thromboembolic risk have higher CRP levels than control subjects. There is no data about the influence of anti-inflammatory therapy on atrial fibrillation or its recurrences.
Zyśko
Dorota
D
Katedra i Klinika Kardiologii AM we Wrocławiu.
Gajek
Jacek
J
Mazurek
Walentyna
W
D000210:Acute-Phase Reaction; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000097:blood* / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism; D004554:Electric Countershock; D006325:Heart Atria / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D007249:Inflammation / Q000150:complications* / Q000378:metabolism*; D018836:Inflammation Mediators / Q000097:blood; D011379:Prognosis; D012008:Recurrence; D012307:Risk Factors
D000889:Anti-Arrhythmia Agents; D015415:Biomarkers; D018836:Inflammation Mediators; D002097:C-Reactive Protein